GLOBAL CHI BC (01757) announces its layout in the AI anti-aging track, and will work together with Sumi Skin and Dipu Xingzhou to promote industry upgrades.

On March 19th, GLOBAL CHI BC (01757) officially announced in Hong Kong that the company is strategically entering the field of AI anti-aging, aiming to upgrade the health and medical beauty industry through technology. The company plans to leverage its listed platform advantage to integrate artificial intelligence, biological data, and clinical anti-aging technology, to build a full-chain AI anti-aging system covering skin quality monitoring, aging assessment, personalized solutions, and results tracking. This strategic layout deeply involves multiple high-quality industry partners, including FAMEGLOW (08603), a Hong Kong medical beauty listed company, and the joint venture between biotechnology company MIRXES-B (02629) and Japanese pharmaceutical company NAGAWA; as well as DEEPEXI TECH (01384), a Hong Kong stock AI solution provider, that provides AI scene-based landing services. FAMEGLOW will introduce top-notch clinical anti-aging testing technology from Japan through deep cooperation with NAGAWA and MIRXES-B, combined with the clinical research and development capabilities of Singapore's MI-RAY, to synergize with the AI technology of GLOBAL CHI BC and DEEPEXI TECH, promoting comprehensive anti-aging services to be upgraded to intelligent, scientific, and global standards, and creating a benchmark for high-end anti-aging services in the Asia-Pacific region. DEEPEXI TECH is responsible for providing core technology bases for AI anti-aging through AI large-scale modeling and multi-dimensional biological data modeling, quantifying aging indicators, precise analysis of blood reports, and recommending personalized components and solutions. Currently, GLOBAL CHI BC is expanding its financial business in Hong Kong through securities and trusts, and in mainland China, it focuses on the "big medical beauty, big health" track through its subsidiary Weichen Medical Technology Group and Tongfan Health Technology Group. The layout of AI anti-aging this time is the technological empowerment and scenario expansion based on existing business foundations. At the same time, the company plans to develop a comprehensive e-commerce platform, integrating online transactions, smart supply chain management, and digital marketing services, to build a integrated ecosystem for Wuxi Online Offline Communication Information Technology Co., Ltd. Mr. Zhou Zhenlin, Chairman of GLOBAL CHI BC, stated that AI anti-aging is a key move for the company's diversified development, and the company will collaborate with FAMEGLOW, DEEPEXI TECH, as well as internationally high-quality partners such as biotechnology companies from Singapore and renowned pharmaceutical companies from Japan, to promote the full-chain industrial layout of "AI technology + clinical anti-aging + biological research and development + business operations". In the future, the company will continue to invest in technology research and development and market expansion, integrate global anti-aging core resources, create a highly recognizable AI anti-aging benchmark project in the Hong Kong stock market, and create long-term value for shareholders and the market.